patients and the healthcare system. In oncology, 15 Biosimilars halved rising drug spending. At a recent CME by Pfizer Pakistan Ltd., Sobia Akhter, Head of Pharmacy at Cancer Foundation Hospital, highlighted Biosimilars’ role in healthcare. They enhance patient access to cost-effective, secure, and effective biologics, contributing to sustainable healthcare
